The average one-year price target for Maze Therapeutics (NasdaqGM:MAZE) has been revised to $44.12 / share. This is an increase of 11.37% from the prior estimate of $39.61 dated November 14, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback